GREXIME TABLETS (CEFUROXIME AXETILE TABLETS 500 MG USP)

NAFDAC REG. NUMBER: B4-3667

COMPOSITION: Each film-coated tablet contains 500 mg of Cefuroxime Axetil (Armophorous) U.S.P

PRODUCT PACKAGING: 10 white, oblong-shaped tablets in an Alu-Alu blister (1 blister of 10 tablets)

INDICATIONS: 

GREXIME is indicated only for the treatment of infections caused by susceptible strains of the following organisms in the following infections:

• Pharyngitis and tonsillitis caused by Streptococcus pyogenes.

• Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (ampicillin- sensitive and resistant strains), Moraxella (Branhamella) catarrhalis and Streptococcus pyogenes.

• Sinusitis caused by Streptococcus pneumoniae and Haemophilus influenzae.

• Acute and chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (ampicillin-sensitive strains) and Haemophilus parainfluenzae (ampicillin-sensitive strains).

• Acute uncomplicated cystitis caused by Escherichia coli and Klebsiella pneumoniae.

• Lyme disease caused by Borrelia burgdorferi